Role of rifaximin in reducing infectious complications in acute pancreatitis
Not Applicable
- Conditions
- Health Condition 1: K859- Acute pancreatitis, unspecified
- Registration Number
- CTRI/2022/07/043978
- Lead Sponsor
- Anurag Kumar Tiwari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients aged 18 years to 65 years presenting with their first attack of acute pancreatitis within first 14 days from onset of pancreatitis and have systemic inflammatory response syndrome (SIRS) at presentation will be included in the study.
Exclusion Criteria
Patients with previous history of pancreatic disease, evidence of active infection at presentation, presence of co-morbid malignancy, presence of obesity [BMI >35kg/msq] and not giving consent for study will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method